Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wang, Yu  [Clear All Filters]
2020
Wang, Z., Li, J., Wang, Y., Wang, L., Yin, Y., Yin, L., Yang, H., and Yin, Y. (2020). Dietary vitamin A affects growth performance, intestinal development and functions in weaned piglets by affecting intestinal stem cells.J Anim Sci.
Zhang, J.-M., Xu, Y., Gale, R.P., Wu, L.-X., Zhang, J., Feng, Y.-H., Qin, Y.-Z., Jiang, H., Jiang, Q., Jiang, B., et al. (2020). DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia.Br J Haematol.
Zeng, Q.-Z., Zhang, Y.-Y., Wu, Y.-J., Zhang, Z.-Y., Zhang, J.-N., Fu, H.-X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Mo, X.-D., et al. (2020). Frequency, risk factors and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Liu, J., Gao, H., Xu, L.-P., Mo, X.-D., Liu, R., Liang, S., Wu, N., Wang, M., Wang, Z., Chang, Y.-J., et al. (2020). Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2 T cells activities after hematopoietic transplantation for blood malignancies.J Immunother Cancer8.
Guan, Z., Wang, Y., Wang, Y., Liu, X., Wang, Y., Zhang, W., Chi, X.M., Dong, Y., Liu, X., Shao, S., et al. (2020). Long non-coding RNA LOC100133669 promotes cell proliferation in oesophageal squamous cell carcinoma.Cell Prolife12750.
Bai, L., Cheng, Y.-F., Lu, A.-D., Suo, P., Wang, Y., Zuo, Y.-X., Yan, C.-H., Wu, J., Jia, Y.-P., Sun, Y.-Q., et al. (2020). Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.Leuk Res91, 106333.
2019
Hu, Q., Huang, L., Zhao, C., Shen, Y., Zheng, X.-F., Wang, Y., Zhou, C.-H., and Wu, Y.-Q. (2019). Ca-PKCα-ERK1/2 signaling pathway is involved in the suppressive effect of propofol on proliferation of neural stem cells from the neonatal rat hippocampus.Brain Res Bull.
Lutfi, F., Iv, W.Paul Skelt, Wang, Y., Rosenau, E., Farhadfar, N., Murthy, H., Cogle, C.R., Brown, R., Hiemenz, J., Wingard, J.R., et al. (2019). Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients.Hematol Oncol Stem Cell Ther.
Ma, R., Huang, X.-J., Xu, L.-P., Liu, K.-Y., Zhang, X.-H., Yan, C.-H., Han, W., Wang, F.-R., Chen, Y.-H., Chen, H., et al. (2019). Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies.Biol Blood Marrow Transplant.
Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 19.Biol Blood Marrow Transplant.
Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., et al. (2019). Corrigendum to 'Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study' [Biology of Blood and Marrow Transplantation 23/8 (.Biol Blood Marrow Transplant.
Yan, C.-H., Liu, Q.-F., Wu, D.-P., Zhang, X., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, H., Bai, H., Huang, F., et al. (2019). Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor.Biol Blood Marrow Transplant.
Yu, X., Cao, X., Yan, H., Luo, X.-Y., Zhao, X., Sun, Y., Wang, Y., Xu, L., Zhang, X., Chang, Y., et al. (2019). Delay expression of NKp30 on NK cells correlates with long-term mycophenolate mofetil treatment and higher EBV viremia post allogenic hematological stem cells transplantation.Clin Immunol.
Zhao, X.-Y., Yu, X.-X., Xu, Z.-L., Cao, X.-H., Huo, M.-R., Zhao, X.-S., Chang, Y.-J., Wang, Y., Zhang, X.-H., Xu, L.-P., et al. (2019). Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.Blood Adv3, 4312-4325.
Zhang, J., Zhao, J., Chen, Y., Shi, H., Huang, X., Wang, Y., Wang, Y., Wei, Y., Xue, W., and Han, J. (2019). Effect of mGluR7 on proliferation of human embryonic neural stem cells.Medicine (Baltimore)98, e14683.
Jing, L., Ruan, Z., Sun, H., Li, Q., Han, L., Huang, L., Yu, S., Wang, Y., Guo, H., and Jiao, M. (2019). Epithelial-mesenchymal transition induced cancer-stem-cell-like characteristics in hepatocellular carcinoma.J Cell Physiol.
Zhao, X.-Y., Pei, X.-Y., Chang, Y.-J., Yu, X.-X., Xu, L.-P., Wang, Y., Zhang, X.-H., Liu, K.-Y., and Huang, X.-J. (2019). First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation.Clin Infect Dis.
Zhang, Y.-Y., Mo, X.-D., Zhang, X.-H., Xu, L.-P., Wang, Y., Yan, C.-H., Chen, H., Chen, Y.-H., Han, W., Wang, F.-R., et al. (2019). FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.Bone Marrow Transplant.
Wen, Q., Kong, Y., Zhao, H.-Y., Zhang, Y.-Y., Han, T.-T., Wang, Y., Xu, L.-P., Zhang, X.-H., and Huang, X.-J. (2019). G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant.
Wang, X.-L., Han, W., Zhao, P., Liu, X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Zhang, Y.-Y., Mo, X.-D., Wang, Y., et al. (2019). Incidence, Risk Factors, Outcomes and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant.
Wang, Y., Tatham, M.H., Schmidt-Heck, W., Swann, C., Singh-Dolt, K., Meseguer-Ripolles, J., Lucendo-Villarin, B., Kunath, T., Rudd, T.R., Smith, A.J.H., et al. (2019). Multiomics Analyses of HNF4α Protein Domain Function during Human Pluripotent Stem Cell Differentiation.Iscience16, 206-217.
Hu, L., Wang, Q., Zhang, X., Xu, L., Wang, Y., Yan, C., Chen, H., Chen, Y., Liu, K., Wang, H., et al. (2019). Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation.Front Med.
Wang, X.-Y., Fan, Q.-Z., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., et al. (2019). The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia.Cytometry B Clin Cytom.
Fu, H., Zhao, J., Xu, L., Liu, K., Wang, Y., Chen, H., Han, W., Wang, J., Wang, F., Huang, X., et al. (2019). Reduced β2-GPI is associated with increased platelet aggregation and activation in patients with prolonged isolated thrombocytopenia after allo-HSCT.Sci China Life Sci.
Xuan, L., Wang, Y., Chen, J., Jiang, E., Gao, L., Wu, B., Deng, L., Liang, X., Huang, F., Fan, Z., et al. (2019). Sorafenib therapy is associated with improved outcomes for FLT3-ITD AML relapsing after allo-HSCT.Biol Blood Marrow Transplant.

Pages